Yahoo India Web Search

Search results

  1. Jun 20, 2024 · Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.

  2. Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

  3. 3 days ago · Jazz Investments I Limited (the "Issuer"), a subsidiary of Jazz Pharmaceuticals, announced that it provided written notice to the exchange agent, the trustee and the holders of its 2.000% ...

  4. 3 days ago · Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing ...

  5. Feb 28, 2024 · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2023 and provided guidance for 2024.

  6. Dec 8, 2023 · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented updated data from the Phase 2a trial of investigational zanidatamab, a HER2-targeted bispecific antibody, in combination with...

  7. Jun 28, 2022 · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options.

  8. Jul 26, 2024 · JAZZ | Complete Jazz Pharmaceuticals PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  9. Jul 26, 2024 · Get a real-time Jazz Pharmaceuticals plc (JAZZ) stock price quote with breaking news, financials, statistics, charts and more.

  10. 3 days ago · Jazz Pharmaceuticals plc. ( NASDAQ: JAZZ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET. Company Participants. Andrea Flynn - Vice President and Head-Investor Relations. Bruce Cozadd ...